Barrington Research upgraded Haemonetics (NYSE: HAE) from Market Perform to Outperform with a price target of $41.00.

For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.

Shares of Haemonetics closed at $36.84 yesterday.